GSK plc (GSK) announces the commencement of its share buyback programme (the “Programme”), as announced in its 2024 full year results announcement published on 5th February, 2025 (the “FY24 Results ...

Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...

For the study, published in Open Forum Infectious Diseases, a team led by a University of Virginia (UVA) researcher and PRIME ...

GSK PLC closed 20.35% short of its 52-week high of £18.24, which the company achieved on May 16th.

Belgium plans to reinforce its global competitiveness in clinical research as the new government sets an ambitious course for pharma progress.

European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.28% to 1,406.36 on the S&P Europe Select ADR Index. From continental ...

Get the latest news today on Vega Jewellers Ltd. Follow Business Standard for the complete news coverage and key information about the Vega Jewellers Ltd.

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...